AI assistant
AGENUS INC — Director's Dealing 2014
Jul 1, 2014
34023_dirs_2014-07-01_7213544c-a5f9-4728-9697-0b3db9338494.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2014-06-27
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-27 | Common Stock | J | 300000 | $3.57 | Disposed | 1379413 | Direct |
| 2014-06-27 | Common Stock | J | 69846 | $3.435 | Disposed | 1309567 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 304046 | Indirect |
Footnotes
F1: Represents deopsit of Agenus Inc. common stock into the Garo Armen 2014 2 Year GRAT.
F2: Represents Agenus Inc. common stock donated to the Children of Armenia Fund.
F3: Dr. Armen is trustee and has investment authority for the Garo Armen 2014 2 Year GRAT holding 300,000 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.